VANC PHARMACEUTICALS INC. ("NPH") [formerly Nuva Pharmaceuticals Inc. ("NPH")] BULLETIN TYPE: Name Change BULLETIN DATE: August 6, 2014 TSX Venture Tier 2 Company
Pursuant to a resolution passed July 23, 2014, the Company has changed its name as follows. There is no consolidation of capital.
Effective at the opening on Thursday, August 7, 2014, the common shares of Vanc Pharmaceuticals Inc. will commence trading on TSX Venture Exchange, and the common shares of Nuva Pharmaceuticals Inc. will be delisted. The Company is classified as a "Developing, Manufacturing and Selling Infection Control Products" company.
Capitalization: Unlimited shares with no par value of which 36,767,074 shares are issued and outstanding Escrow: 6,412,500 shares subject to Escrow
Transfer Agent: Computershare Investors Services Inc. Trading Symbol: NPH (UNCHANGED) CUSIP Number: 92143R105 (new) ________________________________________
|
|